AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Vertical Aerospace, you really have to believe that eVTOLs move from prototype to a certified, scaled service within a few years, before the cash runway runs out. The Valo launch and fresh MoUs with Héli Air Monaco, Skyports and Bristow help the story feel more tangible, because they tie a specific aircraft to defined routes, operators and timelines rather than abstract future demand. That said, near term the key catalysts still look heavily regulatory and financial: achieving full transition flight on the VX4, converting MoUs into binding orders, and securing fresh capital without severe dilution, all against a backdrop of no meaningful revenue and negative equity. The sharp 7‑day share price pullback suggests the market is not treating the new announcements as game‑changing just yet.
However, there is one funding risk in particular that current and potential shareholders should not overlook. Upon reviewing our latest valuation report, Vertical Aerospace's share price might be too optimistic.Explore 5 other fair value estimates on Vertical Aerospace - why the stock might be worth over 10x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com